Extended release carbamazepine in the treatment of pathological gambling: An open-label study

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 5, 2008, Pages 1191-1194

  Black, Donald W ^a   Shaw, Martha C ^a   Allen, Jeff ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Carbamazepine; Impulse control disorders; Pathological gambling

Indexed keywords

CARBAMAZEPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON COLD SYMPTOM; CONFUSION; CONSTIPATION; DIARRHEA; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HOT FLUSH; HUMAN; IMPULSE CONTROL DISORDER; LEUKOCYTE COUNT; MALE; MUSCLE TWITCH; OPEN STUDY; PATHOLOGICAL GAMBLING; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE; PSYCHOPHARMACOTHERAPY; RASH; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SOMNOLENCE; SUSTAINED RELEASE FORMULATION; TREATMENT OUTCOME; YALE BROWN OBSESSIVE COMPULSIVE SCALE MODIFIED FOR PATHOLOGICAL GAMBLING;

ADULT; AGED; ANTICONVULSANTS; CARBAMAZEPINE; DRUG DELIVERY SYSTEMS; DRUG EVALUATION; FEMALE; FOLLOW-UP STUDIES; GAMBLING; HUMANS; IMPULSE CONTROL DISORDERS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES;

EID: 49849102499     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.02.013     Document Type: Article

References (40)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition text revision (2000), American Psychiatric Press, Washington, DC
2. Black D.W., and Moyer T. Clinical features and psychiatric comorbidity in 30 subjects reporting pathological gambling behavior. Psychiatr Serv 49 (1998) 1434-1439
3. Black D.W., Moyer T., and Scholsser S. Quality of life and family history in pathological gambling. J Nerv Ment Dis 191 (2003) 124-126
4. Black D.W. An open-label trial of bupropion in the treatment of pathological gambling. J Clin Psychopharmacol 24 (2004) 108-110
5. Black D.W., Arndt S., Coryell W., Argo T., Forbush K.T., Shaw M., et al. Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study. J Clin Psychopharmacol 27 (2007) 143-150
6. Black D.W., Shaw M., and Allen J. An open label study of escitalopram in the treatment of pathological gambling. Clin Neuropharmacol 30 (2007) 206-212
7. Blanco C., Petkova E., Ibanez A., and Saiz-Ruiz J. A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry 63 (2002) 44-48
8. Blaszczynski A., McConaghy N., and Frankova A. Control versus abstinence in the treatment of pathological gambling: a two to nine year follow up. Br J Addict 86 (1991) 299-306
9. Cunningham-Williams R., and Cottler L.B. The epidemiology of pathological gambling. Sem Clin Neuropsychiatry 6 (2001) 155-166
10. Dannon P., Lowengrub K., Gonopolski Y., Musin E., and Kotler M. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. Clin Neuropharmacol 28 (2005) 6-10
11. Dannon P., Lowengrub K., Musin E., Gonopolski Y., and Kotler M. Sustained-release bupropion in the treatment of SSRI nonresponder pathologic gamblers: pilot study and review of the literature. Therapy 2 (2005) 753-757
12. Dannon P., Lowengrup K., Musin E., Gonopolski Y., and Kotler M. Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study. J Clin Psychopharmacol 25 (2005) 593-596
13. DeCaria C.M., Hollander E., and Begas T. Reliability and validity of a pathological gambling Modification of the Yale-Brown Obsessive-Compulsive Scale: Preliminary findings. Third International Conference on OCD, Madeira, Portugal, September (1998)
14. Endicott J., Spitzer R.L., Fleiss J.L., and Cohen J. The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33 (1976) 766-771
15. Grant J.E., Kim S.W., and Odlaug B.L. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry 66 (2007) 652-657
16. Grant J.E., Potenza M.N., Blanco C., Ibanez A., Stevens L., Hektner J.M., et al. Paroxetine treatment of pathological gambling: a multi-center randomized controlled trial. Int Clin Psychopharmacol 18 (2003) 243-249
17. Grant J.E., and Potenza M.N. Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label study with double-blind discontinuation. Int Clin Psychopharmacol 21 (2006) 203-209
18. Grant J.E., Potenza M.N., Hollander E., Cunningham-Williams R., Nurminen T., Smits G., et al. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry 163 (2006) 303-312
19. Guy W. ECDEU assessment manual for psychopharmacology (1976), U.S. Department of HEW Publication, Washington, DC 217-222
20. Haller R., and Hinterhuber H. Treatment of pathological gambling with carbamazepine (letter). Pharmacopsychiatry 27 (1994) 129
21. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6 (1967) 278-296
22. Hollander E., Buchalter A.J., and DeCaria C.M. Pathological gambling. Psychiatr Clin NA 23 (2000) 629-642
23. Hollander E., DeCaria C., Finkell J.N., Begaz T., Wong C.M., and Cartwright C. A randomized double-blind fluvoxamine/placebo crossover trial in pathological gambling. Biol Psychiatry 47 (2000) 813-817
24. Hollander E., Good E., Pallanti S., Rossi N.B., and Baker B. Pharmacologic treatment of pathological gambling. J Gambling Stud 21 (2005) 101-110
25. Hollander E., Pallanti S., Allen A., Sood E., and Rossi N.B. Does sustained- release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?. Am J Psychiatry 162 (2005) 137-145
26. Kim S.W., Grant J.E., Adson D.E., and Shin Y.C. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 49 (2001) 914-921
27. Kim S.W., Grant J.E., Adson D.E., Shin Y.C., and Zaninelli R. A double-blind placebo controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry 63 (2002) 501-507
28. Lesieur H.R., and Blume S.B. The South Oaks Gambling Screen (SOGS): a new instrument for identification of pathological gamblers. Am J Psychiatry 144 (1987) 1184-1188
29. McElroy S.L., Pope Jr. H.G., Keck P.E., Hudson J.I., Phillips K.A., and Strakowski S.M. Are impulse-control disorders related to bipolar disorder ?. Compr Psychiatry 37 (1996) 229-240
30. Moskowitz J.A. Lithium and lady luck: use of lithium carbonate in compulsive gambling. NY State J Med 80 (1980) 785-788
31. National Opinion Research Center at the University of Chicago (NORC). Gambling impact and behavior study, report to the national gambling impact study commission (1999) April 1
32. Ovsiew F. Antiepileptic drugs in psychiatry. J Neurol Neurosurg Psychiatry 75 (2004) 1655-1661
33. Pallanti S., Quercioloi L., Sood E., and Hollander E. Lithium and valproate treatment of pathological gambling: a randomized single-blind study. J Clin Psychiatry 63 (2002) 559-564
34. Pallanti S., Rossi N.B., Sood E., and Hollander E. Nefazodone treatment of pathological gambling: a prospective open-label controlled trial. J Clin Psychiatry 63 (2002) 1034-1039
35. Petry N.M., and Kiluk B.D. Suicide ideation and attempts in treatment-seeking pathological gamblers. J Nerv Ment Dis 190 (2002) 462-469
36. Pfohl B., Zimmerman M., and Blum N. A Structured Interview for DSM-IV Personality (SIDP-IV) (1997), American Psychiatric Press, Washington, DC
37. Sheehan D.V. The anxiety disease (1986), Bantam Books, Inc, New York, NY
38. Sobell L.C. Alcohol time line followback users manual (1995), Addiction Research Foundation, Toronto, Canada
39. Spitzer R.L., Williams J.B.W., and Gibbon M. Structured Clinical Interview for DSM-IV (1994), New York State Psychiatric Institute, Biometrics Research, New York
40. Zimmerman M., Breen R.B., and Posternak M.A. An open-label study of citalopram in the treatment of pathological gambling. J Clin Psychiatry 63 (2002) 44-48